ClinX Names Kelli Gatlin Vice President of Sales and Marketing
ClinX, parent company of ClinEdge, BTC Network and GuideStar Research, provides clinical trial management solutions to pharmaceutical companies and research facilities.
BOSTON, MA – September 18, 2020 – ClinX and its portfolio companies, ClinEdge, BTC Network and Guidestar Research, are pleased to announce the appointment of Kelli Gatlin as Vice President of Sales and Marketing. Today’s announcement expands on the operations growth strategy that strives to bring in top talent to support the continued growth of the company and its expanding suite of clinical trial business solutions.
In this newly developed role, Kelli will collaborate with pharmaceutical, biotech, CROs, and research sites to help advance the company’s commitment to building and managing trial solutions that connect and empower participants and healthcare professionals within the clinical trial ecosystem. Prior to her role with ClinX, Kelli led the Sales Operations team at DrugDev, Inc., an IQVIA company as Director of Sales Operations. Kelli’s experience will be instrumental in leading customer, patient, and research site engagement strategies for decentralized and traditional study solutions.
“We are thrilled to welcome Kelli to our team as she brings substantial experience in building integrated customer partnership programs, sales, and marketing operations. Kelli has demonstrated great vision and leadership, and this passion will be a great addition to ClinX,” said Christian Burns, Co-Founder and President of ClinEdge.
One of Kelli’s first initiatives will be leading the customer partnership program which has recently expanded its multi-service integrated offerings for key clients where ClinEdge is providing end to end support for the research site and patient engagement lifecycles. She will be undertaking a broad portfolio of responsibilities with a focus on pipeline management and streamlining processes that enable our client strategy development and marketing teams to continue to focus on strategy enhancements and delivery improvements.
Al Peters, ClinX Co-Founder and President of BTC Network added, “Automation, streamlined operations, and increased efficiencies have been at the center of our growth in 2020, and we are excited to bring Kelli onboard to help further those goals and ultimately help us to deliver better clinical trial solutions to the industry.”
Kelli has held other various sales and marketing titles within the industry where she has spearheaded and implemented internal sales processes to complement growth and increase client and company sales operations. Kelli brings over two decades of experience leading and aligning cross-functional teams and developing roadmaps for operational improvements.
ClinX and its portfolio companies, ClinEdge, BTC Network and GuideStar Research, provide a full suite of clinical and outsourced business services to clinical research institutions, pharmaceutical companies, and CROs. The companies include: two global networks of research clinics, marketing and creative design, patient recruitment and retention, patient travel services, and consulting and financial services to both private site and hospital-based research institutions. With extensive experience across various indications representing all therapeutic areas, the three companies have helped clients successfully conduct thousands of clinical studies by maximizing clinical research operations, minimizing enrollment times, and improving overall business performance. To learn more about ClinX and its portfolio companies visit www.Clin-X.com
- Alyssa Kent
- Director of Marketing, ClinX